Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)
CNY 9.45
(1.07%)
CNY 9.45
(1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 96.52 Million | 11.42 Million | 51.13 Million | 43.5 Million | 28.2 Million | 10.23 Million |
| Net Income | 83.85 Million | 30.29 Million | -6.29 Million | 3.28 Million | 15.36 Million | 12.27 Million |
| Depreciation & Amortization | 29.9 Million | 20.02 Million | 22.56 Million | 19.5 Million | 19.83 Million | 17.81 Million |
| Deferred income taxes | -1.29 Million | -1.48 Million | 241 Thousand | -3.16 Million | 186.44 Thousand | -263.7 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -30.45 Million | -43.64 Million | 30.25 Million | 17.97 Million | -10.01 Million | -20.27 Million |
| Other non-cash items | 3.99 Million | 4.75 Million | 4.61 Million | 2.74 Million | 3.02 Million | 423.85 Thousand |
| Investing Cash Flow | -126.35 Million | -12.71 Million | 397.65 Thousand | -17.95 Million | -50.12 Million | -1.75 Million |
| Investments in PPE | -126.35 Million | -13.62 Million | -413.69 Thousand | -18.55 Million | -28.52 Million | -2.77 Million |
| Acquisitions | 1.68 Million | 15 Million | 13.24 Thousand | 668.00 | -22.02 Million | - |
| Investment purchases | - | -15 Million | -20 Million | -20 Million | 165.6 Thousand | -88 Million |
| Sales/Maturities of investments | - | 912.19 Thousand | 798.1 Thousand | 600 Thousand | 258.32 Thousand | 1.01 Million |
| Other Investing Activities | - | 0.78 | 20 Million | 19.99 Million | -3215.30 | 0.48 |
| Financing Cash Flow | -50.71 Million | -19.17 Million | -70.6 Million | 41.01 Million | 10.52 Million | -4.03 Million |
| Debt repayment | -139.5 Million | -20 Million | -70.06 Million | -24 Million | -24.64 Million | - |
| Dividends payments | -3.81 Million | -494.97 Thousand | -534.96 Thousand | -3.03 Million | -3.03 Million | -4.03 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -186.4 Million | 1.32 Million | -534.96 Thousand | 69.99 Million | 39.29 Million | -392 Thousand |
| Accounts receivables | 2.59 Million | -97.19 Million | 34.52 Million | -3.18 Million | -463.13 Thousand | -1.32 Million |
| Accounts payables | -20.1 Million | 62.72 Million | 8.27 Million | 26.35 Million | -3.64 Million | -9.84 Million |
| Inventory | -11.64 Million | -7.69 Million | -12.79 Million | -2.03 Million | -6.08 Million | -8.84 Million |
| Other working capital | -21.39 Million | -1.48 Million | 241 Thousand | -3.16 Million | 186.44 Thousand | -11.43 Million |
| Cash at beginning of period | 369.24 Million | 99.12 Million | 118.18 Million | 51.63 Million | 63.02 Million | 58.58 Million |
| Cash at end of period | 288.69 Million | 97.83 Million | 99.12 Million | 118.18 Million | 51.63 Million | 63.02 Million |
| Capital Expenditure | -126.35 Million | -13.62 Million | -413.69 Thousand | -18.55 Million | -28.52 Million | -2.77 Million |
| Effect of forex changes on cash | - | - | - | -6002.48 | 0.88 | -0.10 |
| Net cash flow / Change in cash | -80.55 Million | -1.28 Million | -19.06 Million | 66.55 Million | -11.39 Million | 4.44 Million |
| Free Cash Flow | -29.83 Million | -2.19 Million | 50.72 Million | 24.94 Million | -314.83 Thousand | 7.45 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.31 Million | -688.08 Thousand | 22.14 Million | 83.85 Million | 14.81 Million | 14.63 Million |
| Depreciation & Amortization | - | 8.05 Million | 8.05 Million | 29.9 Million | 29.9 Million | -14.67 Million |
| Deferred income taxes | - | - | - | -1.29 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 47.78 Million | - | -30.45 Million | -9.05 Million | 77.11 Million |
| Other non-cash items | -2.16 Million | 88.51 Million | 62.56 Million | 3.99 Million | 22.42 Million | -20.81 Million |
| Investing Cash Flow | 3.44 Million | -22.8 Million | -18.38 Million | -126.35 Million | -29.91 Million | -50.82 Million |
| Investments in PPE | -19.61 Million | -16.1 Million | -18.38 Million | -126.35 Million | -29.91 Million | -50.82 Million |
| Acquisitions | -15.6 Million | 16.35 Million | - | 1.68 Million | - | 188.47 Million |
| Investment purchases | 23.04 Million | -23.04 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 23.05 Million | -4984.15 | - | - | - | -188.47 Million |
| Financing Cash Flow | -41.84 Million | -31.08 Million | -27.9 Million | -50.71 Million | -2.93 Million | -86.46 Thousand |
| Debt repayment | -3 Million | -5.75 Million | -27 Million | -139.5 Million | -1.25 Million | - |
| Dividends payments | -34.28 Million | -6.85 Million | -905.17 Thousand | -3.81 Million | -1.07 Million | -1.08 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.56 Million | -25.33 Million | -905.17 Thousand | -186.4 Million | -607 Thousand | 1 Million |
| Accounts receivables | - | 51.81 Million | - | 2.59 Million | 2.59 Million | 35.05 Million |
| Accounts payables | - | - | - | -20.1 Million | - | - |
| Inventory | - | -4.03 Million | - | -11.64 Million | -11.64 Million | 42.05 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 352.99 Million | 327.36 Million | 288.69 Million | 369.24 Million | 263.44 Million | 258.09 Million |
| Cash at end of period | 315.73 Million | 352.99 Million | 327.1 Million | 288.69 Million | 288.69 Million | 263.44 Million |
| Capital Expenditure | -19.61 Million | -16.1 Million | -18.38 Million | -126.35 Million | -29.91 Million | -50.82 Million |
| Effect of forex changes on cash | - | - | - | - | - | 0.88 |
| Net cash flow / Change in cash | -37.25 Million | 25.63 Million | 38.41 Million | -80.55 Million | 25.24 Million | 5.35 Million |
| Free Cash Flow | -18.46 Million | 63.66 Million | 66.32 Million | -29.83 Million | 28.17 Million | 5.43 Million |
QTTB
GLOP-PA
SAVE
TRIN
ASAHIINDIA
NAN